Medications

Combined therapy makes headway for liver cancer

A drug that targets a protein known as phosphatidylserine boosted the response rate for hepatocellular carcinoma (HCC) patients receiving immunotherapy without compromising their safety, according to results of a phase two ...

Diseases, Conditions, Syndromes

Long COVID symptoms in children can vary by age

Symptoms associated with Long COVID in children differ based on the child's age, according to a nationwide, multi-site study. The research will be presented at the Pediatric Academic Societies (PAS) 2024 Meeting, held May ...

Pediatrics

Rotavirus vaccinations in NICU pose minimal risk, finds study

Rotavirus vaccines do not cause significant outbreaks of the disease in neonatal intensive care units (NICUs), according to a new national study. The research will be presented at the Pediatric Academic Societies (PAS) 2024 ...

page 1 from 40